Most of our knowledge regarding the process of protein import into mitochondria has come from research employing fungal systems. This review outlines recent advances in our understanding of this process in mammalian cells. In particular, we focus on the characterisation of cytosolic molecular chaperones that are involved in binding to mitochondrial-targeted preproteins, as well as the identification of both conserved and novel subunits of the import machineries of the outer and inner mitochondrial membranes. We also discuss diseases associated with defects in import and assembly of mitochondrial proteins and what is currently known about the regulation of import in mammals. D
Introduction
The mechanism of protein import into mitochondria is highly conserved across phylogenetic boundaries. Many of the molecular components, first identified in fungal species, have now been found in animal species and the composition of the core translocase components and major receptors is essentially the same (Table 1 ). Additional components have been implicated in the import process in mammalian cells, but their function is still enigmatic. Nevertheless, a comparison of molecular processes across phylogenetic boundaries does assist in appraising various models that attempt to explain the mechanistic steps in protein import.
In many animal cells, protein import, by necessity, has to be separated from cell division, suggesting that mechanisms for regulating the import process must exist. There is still very little information on this aspect although pathways of communication between mitochondria and the nucleus are coming to light. Of particular importance is the emerging realisation that mitochondrial dysfunction is at the centre of many more medical conditions than previously anticipated.
These range from inborn errors of metabolism to later onset neuromuscular disorders and a wide range of often unexpected phenotypes. Despite the fact that many of these are due to nuclear mutations that affect the import, processing and assembly of respiratory chain subunits of the inner mitochondrial membrane, the molecular basis of most of these conditions is yet to be described.
The increasing awareness of the importance of mitochondria in proper cell function is exemplified by recent reviews and editorials on the topic [1 -3] . In this review we will outline the state of knowledge of protein import into mitochondria in mammalian cells and address some of the issues enumerated above.
Cytosolic events in targeting
General pathways for the import of proteins into mitochondria are shown in Fig. 1 . Most matrix-targeted proteins are synthesised in the cytosol as precursors with N-terminal targeting signals that can form positively charged amphipathic a-helices [4] [5] [6] . These signals enable precursors to be targeted to the mitochondrial surface prior to their import. Early studies provided evidence for the existence of both coand posttranslational import into mitochondria [7, 8] . The discovery that ribosomes appear to bind specifically to isolated mitochondria in a GTP-dependent manner and that the binding characteristics are altered in the presence of precursor protein, lends further support to a co-translational import model [9] . However, the establishment of an in vitro import system employing fully translated precursors from rabbit reticulocyte lysates added to isolated mitochondria, has led to the conclusion that proteins can be imported in a posttranslational fashion. Since a prerequisite for membrane translocation is that precursors are in an unfolded or extended conformation, it has been reasoned that cytosolic factors are involved in chaperoning precursors from their site of synthesis to the mitochondrial surface. Subsequently, a number of cytosolic factors have been isolated on the basis of their association with precursor proteins.
Since the typical in vitro import assay utilizes a mammalian translation system, even when fungal mitochondria are used, virtually all cytosolic factors implicated in the import process have been isolated from mammalian sources. Some of these assist in maintaining import competence and others may interact directly with the presequence and thereby assist protein targeting to receptor components on the outer membrane of mitochondria. The constitutively expressed cytosolic isoform of Hsp70 (Hsc70) has been shown to Tim13  Tim10  Tim10a   b   Tim10b   b   Tim9  Tim9  Tim8  Tim8a (DDP1)  Tim8b (DDP2)  Inner membrane  Tim23  Tim23  Tim17  Tim17a  Tim17b  Tim44  Tim44  Tim54  Tim22  Tim22  Tim18  Tim12  Matrix  mtHsp70 (Ssc1p)  mtHsp70  Mge1  hTid (mtDnaJ)  Mdj1  mtGrpE  MPP  MPP  MIP  MIP  Cpn60  Cpn60  Cpn10 Cpn10 a Primary sequence data of these proteins has not been published but they may be homologues to the fungal small Tom proteins.
b Tom10a or Tim10b may be functionally homologous to fungal Tim12. Fig. 1 . Components of the (A) fungal and (B) mammalian mitochondrial protein import apparatus. The general protein import pathways for matrixtargeted precursor proteins containing N-terminal targeting signals (left) and those targeted to the inner membrane (right) are shown. Subunits that are unique to either system are shaded grey. Note that homologues may exist but they have yet to be identified. maintain mitochondrial precursor proteins in an import competent state [10] . When Hsc70 was first immunodepleted from the reticulocyte lysate mix that contained newly synthesised precursor proteins, protein import was disrupted [11] . Only when Hsc70 was present during translation did the precursor protein remain competent for import into mitochondria since addition of purified Hsc70 to the import reaction after precursor synthesis did not restore the import defect [11] . The presence of N-terminal presequences in newly synthesised precursor proteins may prevent their folding and therefore lead to a prolonged association with Hsc70. For example, the mitochondrial isoform of aspartate amino transferase stably binds Hsc70, whereas the cytosolic isoform does not [12] . A small fraction of Hsc70 is associated tightly with the mitochondrial outer membrane [13] , suggesting that a docking mechanism for delivery of precursors to the mitochondrial receptors may exist.
Hsc70 usually performs its chaperone function in association with the co-chaperones DnaJ and GrpE. While there is no information to support a role of the cytosolic GrpE homologue Bag-1 [14] in protein import, two of the three known mammalian cytosolic isoforms of DnaJ, dj2 and dj3 are required for import of some precursor proteins [15 -17] . Based on reticulocyte depletion studies, dj2 and dj3 were shown to be required for import of some precursor proteins, whereas another DnaJ isoform, dj1, was not [16, 17] . The role of Hsc70 and dj2 function in the import process is somewhat removed from their usual role of assisting in the folding of newly synthesised proteins. Instead, their interaction with precursors seems to be retained until their delivery to the mitochondrial receptors [18] . The way in which they achieve this is not known, but what distinguishes mitochondrial precursor proteins from other proteins is the presence of targeting signals and their binding-factors in the cytosol. While Hsc70 plays a role in protein import, it does not appear to be essential for the delivery of all precursors to the mitochondria [18] .
A number of other cytosolic factors implicated to be involved in targeting have been reported and include: targeting factor [19] , a 28-kDa protein affinity purified using a signal peptide; presequence binding factor (PBF; [20, 21] ), a 50-kDa protein purified on affinity resin containing recombinant precursors of ornithine transcarbamylase (pOTC); and mitochondrial import stimulation factor (MSF), a heterodimer of 66 kDa, isolated from rat liver [22] . Aside from the initial reports almost a decade ago, no further characterisation of targeting factor or PBF has been reported. MSF was isolated on the basis of its stimulation of pre-adrenodoxin import [22] . It has been shown to require ATP for its function and it is also sensitive to treatment with N-ethylmaleimide [23, 24] . Not all precursor proteins require MSF for import [25] and this factor appears to have no functional homologue in lower eukaryotes. Nevertheless, based on reconstitution experiments with yeast mitochondria and outer membrane preparations, a model has been proposed whereby MSF delivers precursor proteins to the outer membrane receptor, Tom70. The precursor proteins can then be passed to Tom20 and Tom22 before translocation across the outer membrane [26, 27] . In experiments with the soluble domains of yeast Tom receptors, it has been shown that MSF forms a complex with the cytosolic domain of Tom70 in the presence of precursor protein, with release of MSF and subsequent precursor transfer to the cytosolic domain of Tom20 upon ATP hydrolysis [27] .
The mammalian TOM machinery
Mammalian homologues of fungal translocase components of the outer mitochondrial membrane (TOM) that have been identified to date include the receptors Tom20, Tom22, Tom70 and the channel protein Tom40 (Fig. 1) . Additionally, co-immunoprecipitation experiments using Tom40 antibodies have identified a number of small molecular weight proteins of 10, 7.5 and 5 kDa that may represent homologues of Tom7, Tom6 and Tom5. A human Tom7 has been identified and like its fungal counterparts, is found in association with the core Tom complex (Johnston, Hoogenraad and Ryan, in preparation). The first mammalian Tom subunit to be identified was Tom20 [28 -30] . Although showing more than 50% sequence identity with fungal Tom20, it is a somewhat smaller protein being only 16.3 kDa in size. It is Nterminally anchored by a hydrophobic transmembrane domain and has a 13 kDa cytosolic receptor domain [30] . Human Tom20 was shown to be able complement respiratory defects of yeast cells lacking Tom20 and could interact with other Tom subunits in yeast [28, 29] . Furthermore, antibodies against the soluble domain of human Tom20 were able to inhibit mitochondrial protein import in vitro [29, 30] . Addition of the purified soluble receptor domain of mammalian Tom20 to in vitro import assays was also shown to competitively inhibit the import of a range of mitochondrial-targeted precursor proteins [31, 32] . The ability of the cytosolic domain to fold in association with a mitochondrial signal peptide allowed its structure to be determined by NMR [6] . This structure revealed that an interaction occurred between the hydrophobic face of the amphipathic signal peptide and a cleft formed by stacking of three a-helices in Tom20. The cleft also includes part of the single tetratricopeptide repeat (TPR) domain of the receptor [6] . TPR domains have been found in a number of TOM subunits and these domains have been implicated to be involved in mediating protein -protein interactions [33] . The association of the hydrophobic face of the presequence with Tom20 leaves the basic face to interact with some other, yet to be identified component of the import machinery. Potential candidates for interaction may include the Tom22 receptor, or cytosolic chaperones that may dock onto Tom20 for precursor delivery. Whereas Tom20 has a highly acidic carboxy-terminus (EDDVE) that protrudes towards the cytosol, this region was not in contact with the signal peptide in the 3-D structure [6] . Interestingly, complementation studies with mutant forms of human Tom20 in yeast suggested that neither the TPR domain nor the carboxy-terminal acidic domain were essential for the activity of Tom20 [34] . It is of interest to note that yeast Tom20 also has this acidic domain whereas Tom20 from Neurospora crassa does not.
In a surprising finding, it was shown that overexpression of human Tom20 in mammalian cells causes a major disruption in the morphology and distribution of mitochondria [35] , resulting in the perinuclear aggregation of mitochondria. This suggests that Tom20 may be implicated in the association of mitochondria with the cytoskeleton of mammalian cells and that a disturbance in the stoichiometry of the Tom components disrupts this association. This observation supports previous findings that Tom20-deficient N. crassa cells contain mitochondria that have reduced numbers of cristae [36] , also implicating a role for Tom20 in the maintenance of fungal mitochondrial morphology. Overexpression of the receptor also produced a dominant negative inhibitory effect on import of the mitochondrial matrix-targeted precursor protein, pOTC. Deletion analysis of hTom20 [37] showed that a linker region between the transmembrane domain and a glutamine rich domain [38] is essential for the dominant negative effect.
Mammalian homologues of the Tom70 [39] and Tom22 [40] receptors have also been identified. As in fungi, Tom70 does not remain associated with the core Tom complex following separation by native PAGE, whereas Tom22 is tightly associated with Tom40 in a complex of between 380 and 400 kDa [41] . Although mammalian Tom20 is also loosely associated with the Tom complex, it nevertheless associates with Tom22 since the two Tom receptors can be co-immunoprecipitated with antibodies specific for either receptor [40, 41] . Both fungal and mammalian counterparts of Tom22 have a carboxyterminal intermembrane space domain and an N-terminal cytosolic receptor domain. Mammalian Tom22 is substantially smaller than its fungal homologue, having a size of 15.5 kDa. However, like fungal Tom22, it has a strongly acidic N-terminal domain, which interacts with mitochondrial precursor proteins [40] . On the other hand, the intermembrane space domain of mammalian Tom22 shows little sequence similarity to the fungal ortholog, particularly in as far as it lacks the acidic character of the fungal receptor. This raises questions about the ''acidchain'' hypothesis, which proposes a pathway involving electrostatic interaction of increasing affinity between the basic targeting signals of precursors, and acidic domains on import subunits on either side of the outer membrane. Such conclusions were based on studies with soluble domains of fungal receptors, particularly the cytosolic and intermembrane space acid domains of Tom22 [42] . This has led to a modification of the ''acid-chain'' hypothesis to a ''binding chain'' hypothesis, which proposes that there is a sequence of increasing affinities for interactive sites on translocation components with which precursor proteins interact during import [43] . This modification also can account for the translocation of precursor proteins that lack typical N-terminal targeting signals, such as many intermembrane space and some innermembrane destined proteins.
Rat [41] and human [44] Tom40 homologues have also been identified as 38-kDa outer membrane proteins with structural similarity to fungal Tom40. Rat Tom40 was found to be buried in the outer membrane and only accessible to protease digestion from the intermembrane space side. Furthermore, a precursor protein containing a folded cytosolic domain arrested at mitochondrial translocation sites was found to be associated with rat Tom40 [41] .
A number of additional proteins associated with the mitochondrial outer membrane have also been implicated in protein import. Metaxin is a C-terminally anchored protein that was proposed to be a component of the translocation machinery in mammalian cells based on the ability of antibodies against metaxin to inhibit import of preadrenodoxin [45] . The metaxin gene is located between the glucocerebrosidase and thrombospondin 3 genes in mice and shown to be required for embryonic development [46] . Metaxin shows some homology to yeast Tom37. Tom37 was reported to associate with Tom70 and to facilitate mitochondrial import [47] . Although overexpression of metaxin in mammalian cells results in a mild inhibition of mitochondrial protein import, it is not associated with subunits of the TOM complex [41, 44] . A cytosolic isoform of metaxin, termed metaxin 2, was later identified and found to interact with metaxin 1 at the surface of the mitochondrial outer membrane [48] . Antibodies against metaxin 2 did not prevent the import of preadrenodoxin into mitochondria [48] . More recently, Metaxin 1 has been reported to be required for tumor necrosis factor-induced necrotic and apoptotic cell death [49] . The relationship between apoptotic cell death and mitochondrial protein import, if any, is yet to be investigated. OM37 is a 37-kDa mitochondrial outer membrane protein identified from mammalian cells whose antibodies were also found to inhibit protein import [25] . It apparently has no fungal homologue and is proposed to function as the receptor for the MSF-precursor protein complex [25] . OM37 was not co-immunoprecipitated with Tom40 or Tom20 antibodies [41] . Human Tom34, a TPR containing protein, was found to have sequence homology with Tom70 [50] . Specific antibodies, as well as the soluble cytosolic domain of Tom34, were shown to inhibit the import of a subset of mitochondrial precursors [51] . Tom34 is found partially in the cytosol and partially associated with the mitochondrial outer membrane as a peripheral membrane protein [51] .
The function and contribution of the mammalian proteins described above in the process of mitochondrial protein import remains unresolved. It may be that these proteins are responsible for the stimulation of import of only a minor number of precursor proteins. Interestingly, human Tom34 was identified in a yeast 2-hybrid screen, as a protein that binds to the carboxy-terminal fragment of Hsp90, the interconnection being through the Tom34 TPR domain [33] .
The mammalian TIM machinery
Whereas the outer mitochondrial membrane contains a single TOM preprotein translocase, the inner membrane contains two distinct TIM translocases, including a suite of small TIM components in the intermembrane space (reviewed elsewhere in this issue). A number of mammalian homologues of fungal TIM components have been identified and at least one of these proteins has been of particular interest since mutations in its gene have been implicated in causing a neurodegenerative disorder.
The TIM23 complex containing the subunits Tim23, Tim17 and Tim44 is involved in the import of those precursor proteins containing typical N-terminal targeting signals [43] . These include all matrix targeted precursors as well as some precursors that additionally contain hydrophobic stop-transfer signals, which lead to their arrest in the inner membrane. Homologous subunits of the yeast TIM23 complex have been found in mammals. However, while single genes encode human Tim23 and Tim44, two genes encoding Tim17 have been found [52, 53] . Both isoforms of Tim17 seem to be ubiquitously expressed and they each form separate complexes with Tim23-although the reason for this is not known [53] . Mammalian Tim44 was first identified by its fivefold increase in expression in diabetic newborn mice [54] . Interestingly, overexpression of this protein led to some mitochondria displaying paracrystalline cristae. The upregulation of Tim44 (and perhaps other TIM and TOM components), as a response to elevated glucose concentrations arising from diabetes, may lead to the more efficient import of nuclear-encoded mitochondrial enzymes involved in oxidative phosphorylation. While fungal Tim44 is tightly associated with the matrix-face of the inner membrane [55] , mammalian Tim44 is largely found in the soluble matrix fraction [53, 56] . Furthermore, an association of Tim44 with Tim23 and Tim17 has not been observed [53, 56] , although rat Tim44 has been found to associate with matrix Hsp70 in the absence of ATP [56] . In fungi, it has been proposed that Tim44 functions as an anchor for matrix Hsp70, so that this chaperone can bind and assist in the translocation of precursor proteins. ATP hydrolysis is thought to result in structural rearrangements of Hsp70, leading to the generation of force and pulling of precursors into the matrix [43] . A different model suggests that rather than pulling, Hsp70 binding is more passive and prevents the retrograde movement of precursors [57] . Since mammalian Tim44 is largely found in the matrix fraction of mitochondria, it suggests that mtHsp70 in this system may not be able to perform a pulling function. Further characterisation of these components in mammalian mitochondria is necessary to clarify their roles in protein translocation.
The TIM22 complex in yeast is involved in the import of integral inner membrane proteins such as metabolite carrier precursors. The complex consists of the integral membrane subunits Tim22, Tim54 and Tim18, along with a number of small Tims that represent a novel family of zinc finger proteins that contain a conserved Cys4 zinc finger motif [58] . The small Tim proteins most likely serve as molecular chaperones in targeting precursor proteins from the Tom complex across the intermembrane space to the Tim22 insertion complex. They may also facilitate the forward movement of a subset of precursor proteins across the Tom machinery. Mammalian homologues of a number of these Tim proteins have been found [59, 60] . These include human Tim22 as well as numerous small Tim proteins-Tim8a (also known as DDP1), Tim8b (DDP2), Tim9, Tim10a, Tim10b and Tim13. Recent studies indicate that these small Tim proteins perform similar roles to that of their yeast counterparts. Human Tim13 and Tim8 isoforms seem to bind to translocation intermediates of the precursor to Tim23 in the intermembrane space and assist in its movement to the inner membrane [61] . Presumably, these Tim proteins are involved in the import, not just of Tim23, but a number of different inner membrane targeted precursors that exhibit extensive hydrophobic regions. The finding that mutations in the gene encoding Tim8a (DDP1) lead to a neurodegenerative disorder termed Mohr -Tranebjaerg syndrome (or deafness dystonia), has led to conclusions that import defects are somehow responsible for causing this disease [59] .
Processing, folding and assembly
A number of matrix factors have been identified for processing, folding and assembly of proteins imported into mitochondria. The mitochondrial isoform of Hsp70 functions in conjunction with Tim44 and mitochondrial GrpE as a translocation motor (see other contributions in this series). Mammalian homologues of these well-characterized fungal proteins have been identified [53, 56, 62, 63] . Hsp70 has an additional role in protein folding, where it cooperates with mtGrpE and mtDnaJ (or Tid), a recently identified mitochondrial co-chaperone [64] . Once in the matrix, mitochondrial targeting signals (or presequences) are usually processed by certain processing peptidases. These proteases were first identified in mammalian tissues [65, 66] . Mitochondrial processing peptidase (MPP) is a metalloprotease that typically requires arginine residues at À 2 or À 3 from the cleavage point. Proline and glycine are also required for specificity [67, 68] . Some precursor proteins such as pOTC are processed in two steps. The first cleavage is catalyzed by MPP and the second is catalyzed by the mitochondrial intermediate peptidase (MIP) [69] , a zinc metalloprotease that recognises amino-terminal octapeptides as a recognition sequence [70] . Other matrix precursor proteins are not proteolytically processed, such as mammalian rhodanese and Chaperonin 10 [71] .
Following processing, mitochondrial matrix proteins are folded, often with the assistance of molecular chaperones such as the Hsp70 or the chaperonin machineries [72] . Each of these has homologues in eubacteria, such as E. coli, and essentially all of the counterparts of bacterial chaperones have now been identified in fungal and animal species. The mitochondrial GroEL homologue, termed Chaperonin 60 (Cpn60) or Hsp60, was first isolated from human cells [73] while the GroES homologue, Cpn10, was first purified from rat liver [74] . The mammalian genes encoding these two chaperonins were found to be joined by a single bi-directional promoter [75] . Although most of our understanding of chaperone-mediated protein folding has arisen from the study of bacterial systems, mitochondrial substrates for yeast Cpn60 and Cpn10 have recently been examined [76] . Like bacterial GroEL, yeast Cpn60 forms a tetradodecameric structure consisting of two toroidal rings of seven subunits, capped at either end by Cpn10 heptamers. However, while a doubled-ringed structure has been described [77] , the minimal functional unit for mammalian Cpn60 appears to be a single heptameric ring [78] . Little information is available so far on the contribution made by mammalian mitochondrial chaperonins in the folding of newly imported matrix proteins.
Defects in import and assembly
Because of the central role played by mitochondria in the generation of ATP via oxidative phosphorylation, many mitochondrial diseases are characterized by symptoms that express themselves in tissues that are highly dependent on the availability of ATP. Thus, neurological disorders are common outcomes of mitochondrial disorders as well as myopathies and defects arising from deficiencies in secretory tissues such as the pancreas. Although several hundred mutations in mitochondrial resident DNA (mtDNA) have been described since the first report in 1988 [79] , relatively few nuclear gene defects causing mitochondrial disease have been reported. It is interesting to note that a number of diseases not thought to be ''mitochondrial'' are now known to be due to mutations in nuclear genes encoding mitochondrial proteins. These include Friedrich's ataxia, neuroblastic anemia, Wilson's disease (all diseases in metal iron transport), hereditary spastic paraplegia, deafness dystonia (Mohr -Tranebjaerg) syndrome and optic atrophy [1, 59, 80, 81] .
It is also notable that most of the gene defects identified to date do not encode respiratory chain subunits, but rather genes affecting protein import, subunit processing and assembly of complexes. For example, the SURF1 gene has been implicated in the assembly of Complex IV (cytochrome c oxidase), and defects in this gene lead to Leigh's syndrome [82, 83] . Hereditary spastic paraplegia was found to be due to a defect in the SPG7 (paraplegin) gene, encoding a homologue of the yeast AAA protease/chaperone required for the assembly of the ATP synthase complex (complex V); [84] . Deafness dystonia syndrome is caused by mutations in DDP1 [59] , an intermembrane space small Tim protein homologous to yeast Tim8 (see above).
It is of interest to note that so far no defects arising from mutations in TOM components have been described. Given that protein import into mitochondria is a general process essential for cell viability, any mutations in genes encoding subunits of the import machinery would probably result in premature termination, most likely at the embryonic stage of development. A number of diseases have been described, however, that are a result of more specific import defects due to mutations in the presequences of mitochondrial matrix proteins. These include ornithine transcarbamylase [85] ; methylmalonyl-CoA mutase [86] ; and the El a subunit of pyruvate dehydrogenase [87] . Mutations affecting proteolytic processing after import have also been described [88, 89] . In addition, a mutation in peroxisomal L-alanine:-glyoxylate aminotransferase has also been reported that results in the creation of a cryptic mitochondrial targeting signal leading to mistargeting of this protein to mitochondria [90] . Disease states have also been attributed to the decreased expression of matrix-located Cpn60 [91] .
Regulation of import and mitochondrial -nuclear communications
Since most of the genes that regulate the function of mitochondria are located in the nucleus, it is axiomatic that there must be effective communication between mitochondria and the nucleus. For example a classic outcome of defects in oxidative phosphorylation due to mutations in mtDNA is a massive proliferation of mitochondria [1] . Thus, genes for mitochondrial biogenesis must be upregulated and mitochondrial biogenesis must be under some form of control, a process that presumably requires interorganellar communication [92] . Evidence for such communication comes from the substantial changes in gene expression profiles in yeast that have had their mtDNA removed [93] . In mammalian cells, a pathway of signalling has been reported, based on release of calcium by mitochondria via a c1-Jun N-terminal kinase pathway [94] . This signalling occurs in response to both genetic stress caused by the partial deletion of mtDNA and metabolic stress caused by mitochondrial oxidative phosphorylation inhibitors. This pathway is also implicated in tumour progression and metastasis [95] .
Little is known about the regulation and expression of the nuclear genes encoding subunits in the mitochondrial import machinery. While expression analysis of a number of TIM genes indicates that they are constitutively and ubiquitously expressed [53] , it seems that expression of the gene encod-ing human Tom70 is additionally regulated by thyroid hormone [39] . Thyroid hormone is an important regulator of growth and development in mammals and the increased synthesis of import components and the resulting increased import may increase oxidative metabolism in cells. Interestingly, thyroid hormone treatment has been shown to result in the increase in both mitochondrial volume and mitochondrial cristae in cardiac cells while hyperthyroidism leads to increased concentrations of mitochondrial protein content [96, 97] . Analysis of mitochondria from cells treated with thyroid hormone showed an increase in the amount of Tom20 and mtHsp70 along with an increased rate of protein import into the matrix [98] . From this example, it appears that the cell may be able to increase the demands it places on mitochondria by regulating the expression of components of the mitochondrial import apparatus in order to facilitate the metabolic needs of the cell.
